Literature DB >> 15255892

Activity reversal of Tet repressor caused by single amino acid exchanges.

Oliver Scholz1, Eva-Maria Henssler, Johannes Bail, Peter Schubert, Joanna Bogdanska-Urbaniak, Sabine Sopp, Marco Reich, Stefanie Wisshak, Martin Köstner, Ralph Bertram, Wolfgang Hillen.   

Abstract

We explore by extensive mutagenesis regions in the sequence allowing reversal of the allosteric response of Tet repressor. The wild type requires anhydrotetracycline for induction. About 100 mutants are presented, which, in contrast, require the drug for repression. Their mutations are clustered at the interface of the DNA- and inducer-binding domains. This interface consists of a central hydrophobic region surrounded by several hydrogen bonds. While most of the mutants described here contain two to five mutations, we found five positions in this region of TetR, at which single amino acid exchanges lead to activity reversal. They may disrupt the hydrogen-bonding network bordering the domain interface. We assume that the mutations cause a repositioning of the DNA reading head with respect to the effector binding core so that the same conformational change can result in opposite activities. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255892     DOI: 10.1111/j.1365-2958.2004.04159.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  34 in total

1.  proTeOn and proTeOff, new protein devices that inducibly activate bacterial gene expression.

Authors:  Katherine Volzing; Konstantinos Biliouris; Yiannis N Kaznessis
Journal:  ACS Chem Biol       Date:  2011-08-18       Impact factor: 5.100

Review 2.  Tailor-made transcriptional biosensors for optimizing microbial cell factories.

Authors:  Brecht De Paepe; Gert Peters; Pieter Coussement; Jo Maertens; Marjan De Mey
Journal:  J Ind Microbiol Biotechnol       Date:  2016-11-11       Impact factor: 3.346

3.  Evolution-guided engineering of small-molecule biosensors.

Authors:  Tim Snoek; Evan K Chaberski; Francesca Ambri; Stefan Kol; Sara P Bjørn; Bo Pang; Jesus F Barajas; Ditte H Welner; Michael K Jensen; Jay D Keasling
Journal:  Nucleic Acids Res       Date:  2020-01-10       Impact factor: 16.971

Review 4.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

5.  Generating tetracycline-inducible auxotrophy in Escherichia coli and Salmonella enterica serovar Typhimurium by using an insertion element and a hyperactive transposase.

Authors:  Martin Köstner; Britta Schmidt; Ralph Bertram; Wolfgang Hillen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

6.  Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut.

Authors:  Bentley Lim; Michael Zimmermann; Natasha A Barry; Andrew L Goodman
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

7.  The induction of folding cooperativity by ligand binding drives the allosteric response of tetracycline repressor.

Authors:  Sean E Reichheld; Zhou Yu; Alan R Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  New architectures for Tet-on and Tet-off regulation in Staphylococcus aureus.

Authors:  Elena Stary; Rosmarie Gaupp; Sabrina Lechner; Martina Leibig; Evelyn Tichy; Martina Kolb; Ralph Bertram
Journal:  Appl Environ Microbiol       Date:  2009-12-04       Impact factor: 4.792

9.  Silencing Mycobacterium smegmatis by using tetracycline repressors.

Authors:  Xinzheng V Guo; Mercedes Monteleone; Marcus Klotzsche; Annette Kamionka; Wolfgang Hillen; Miriam Braunstein; Sabine Ehrt; Dirk Schnappinger
Journal:  J Bacteriol       Date:  2007-05-04       Impact factor: 3.490

10.  Improved tetracycline repressors for gene silencing in mycobacteria.

Authors:  Marcus Klotzsche; Sabine Ehrt; Dirk Schnappinger
Journal:  Nucleic Acids Res       Date:  2009-01-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.